Headlands Technologies LLC increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 499.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,990 shares of the company's stock after purchasing an additional 49,157 shares during the quarter. Headlands Technologies LLC's holdings in GE HealthCare Technologies were worth $3,776,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $26,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies during the fourth quarter worth $27,000. Montag A & Associates Inc. grew its stake in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company's stock valued at $28,000 after acquiring an additional 175 shares in the last quarter. Transamerica Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock valued at $28,000 after acquiring an additional 262 shares during the last quarter. Finally, MV Capital Management Inc. purchased a new stake in GE HealthCare Technologies in the 4th quarter worth $33,000. Institutional investors own 82.06% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently weighed in on GEHC. BTIG Research restated a "buy" rating and set a $79.00 price objective on shares of GE HealthCare Technologies in a research report on Wednesday, August 19th. Citigroup boosted their target price on GE HealthCare Technologies from $69.00 to $75.00 and gave the stock a "neutral" rating in a research report on Thursday, July 30th. Hovde Group began coverage on GE HealthCare Technologies in a research note on Friday, July 17th. They set a "market perform" rating and a $14.00 price target for the company. UBS Group raised their price target on GE HealthCare Technologies from $67.00 to $73.00 and gave the company a "neutral" rating in a report on Friday, July 31st. Finally, Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an "overweight" rating in a report on Thursday, July 30th. Ten investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $77.73.
Get Our Latest Stock Report on GEHC
GE HealthCare Technologies Stock Down 0.0%
Shares of NASDAQ:GEHC opened at $71.72 on Monday. The company has a market cap of $32.39 billion, a price-to-earnings ratio of 16.45, a PEG ratio of 2.07 and a beta of 0.69. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. The company has a 50-day moving average price of $67.67 and a 200 day moving average price of $69.26.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.04 by $0.09. The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The company's quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.06 earnings per share. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were given a $0.035 dividend. The ex-dividend date was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.21%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.